On-chip perivascular
Journal
Lab on a chip
ISSN: 1473-0189
Titre abrégé: Lab Chip
Pays: England
ID NLM: 101128948
Informations de publication
Date de publication:
15 06 2021
15 06 2021
Historique:
pubmed:
11
5
2021
medline:
29
6
2021
entrez:
10
5
2021
Statut:
ppublish
Résumé
Glioblastoma multiforme (GBM) is the most common and the most aggressive type of primary brain malignancy. Glioblastoma stem-like cells (GSCs) can migrate in vascular niches within or away from the tumour mass, increasing tumour resistance to treatments and contributing to relapses. To study individual GSC migration and their interactions with the perivasculature of the tumour microenvironment, there is a need to develop a human organotypic in vitro model. Herein, we demonstrated a perivascular niche-on-a-chip, in a serum-free condition with gravity-driven flow, that supported the stemness of patient-derived GSCs and foetal neural stem cells grown in a three-dimensional environment (3D). Endothelial cells from three organ origins, (i) human brain microvascular endothelial cells (hCMEC/D3), (ii) human umbilical vein endothelial cells (HUVECs) and, (iii) human lung microvascular endothelial cells (HMVEC-L) formed rounded microvessels within the extracellular-matrix integrated microfluidic chip. By optimising cell extraction protocols, systematic studies were performed to evaluate the effects of serum-free media, 3D cell cultures, and the application of gravity-driven flow on the characteristics of endothelial cells and their co-culture with GSCs. Our results showed the maintenance of adherent and tight junction markers of hCMEC/D3 in the serum-free culture and that gravity-driven flow was essential to support adequate viability of both the microvessel and the GSCs in co-culture (>80% viability at day 3). Endpoint biological assays showed upregulation of neovascularization-related genes (e.g., angiopoietins, vascular endothelial growth factor receptors) in endothelial cells co-cultured with GSCs in contrast to the neural stem cell reference that showed insignificant changes. The on-chip platform further permitted live-cell imaging of GSC - microvessel interaction, enabling quantitative analysis of GSC polarization and migration. Overall, our comparative genotypic (i.e. qPCR) and phenotypic (i.e. vessel permeability and GSC migration) studies showed that organotypic (brain cancer cells-brain endothelial microvessel) interactions differed from those within non-tissue specific vascular niches of human origin. The development and optimization of this on-chip perivascular niche, in a serum-free flowable culture, could provide the next level of complexity of an in vitro system to study the influence of glioma stem cells on brain endothelium.
Identifiants
pubmed: 33969368
doi: 10.1039/d1lc00271f
pmc: PMC8204159
doi:
Substances chimiques
Vascular Endothelial Growth Factor A
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2343-2358Subventions
Organisme : Department of Health
Pays : United Kingdom
Organisme : Cancer Research UK
Pays : United Kingdom
Références
Sci Rep. 2018 Aug 20;8(1):12480
pubmed: 30127372
Neuro Oncol. 2017 Apr 1;19(4):503-513
pubmed: 28062831
Adv Exp Med Biol. 2019;1139:1-21
pubmed: 31134492
Adv Sci (Weinh). 2019 Feb 10;6(8):1801531
pubmed: 31016107
Cancer Res. 2014 Sep 1;74(17):4937-45
pubmed: 24970480
Neuro Oncol. 2014 Sep;16(9):1167-75
pubmed: 24642524
Biomaterials. 2019 Apr;198:63-77
pubmed: 30098794
Cancer Res. 2004 Oct 1;64(19):7011-21
pubmed: 15466194
Future Sci OA. 2017 Mar 02;3(2):FSO173
pubmed: 28670465
Nature. 2006 Dec 7;444(7120):756-60
pubmed: 17051156
Ann N Y Acad Sci. 2009 May;1165:113-20
pubmed: 19538295
Cancer Metastasis Rev. 2009 Jun;28(1-2):113-27
pubmed: 19153673
Nat Commun. 2020 Jan 10;11(1):175
pubmed: 31924752
J Biol Chem. 1999 Oct 22;274(43):30896-905
pubmed: 10521483
Clin Exp Metastasis. 1999 Jul;17(5):423-9
pubmed: 10651309
Biomed Microdevices. 2018 Sep 6;20(3):80
pubmed: 30191323
PLoS One. 2013;8(2):e56910
pubmed: 23437268
Int J Biochem Cell Biol. 2004 Jun;36(6):1046-69
pubmed: 15094120
Oncotarget. 2017 Aug 11;8(40):69185-69197
pubmed: 28978189
Cancer Res. 2009 Sep 15;69(18):7243-51
pubmed: 19738068
Cancer Med. 2014 Aug;3(4):812-24
pubmed: 24810477
Sci Transl Med. 2016 Aug 31;8(354):354re3
pubmed: 27582061
J Pathol. 1992 Dec;168(4):357-63
pubmed: 1484317
Lancet. 2015 Mar 28;385(9974):1206-18
pubmed: 25479696
Circ Res. 2000 Jan 7-21;86(1):24-9
pubmed: 10625301
Sci Rep. 2016 Oct 31;6:36086
pubmed: 27796335
Bioeng Transl Med. 2019 Jan 13;4(2):e10126
pubmed: 31249876
J Biol Chem. 2011 Nov 18;286(46):40025-37
pubmed: 21940631
Acta Neuropathol. 2007 Aug;114(2):97-109
pubmed: 17618441
Sci Rep. 2019 Apr 17;9(1):6199
pubmed: 30996291
Cell Chem Biol. 2017 Sep 21;24(9):1092-1100
pubmed: 28757181
Nat Rev Cancer. 2018 May;18(5):323-336
pubmed: 29520090
Cancer Cell. 2014 Nov 10;26(5):605-22
pubmed: 25517747
Fluids Barriers CNS. 2019 Jan 29;16(1):3
pubmed: 30691500
Cancer Cell. 2018 May 14;33(5):874-889.e7
pubmed: 29681511
Angiogenesis. 2020 Feb;23(1):9-16
pubmed: 31679081
Cell Stem Cell. 2009 Jun 5;4(6):568-80
pubmed: 19497285
Nat Methods. 2018 Aug;15(8):631-639
pubmed: 30038414
Integr Biol (Camb). 2017 Jun 19;9(6):529-538
pubmed: 28488717
Front Oncol. 2019 Mar 06;9:118
pubmed: 30895167
Biomaterials. 2018 Oct;180:117-129
pubmed: 30032046
PLoS One. 2010 Mar 22;5(3):e9808
pubmed: 20339555
Microvasc Res. 2019 Mar;122:60-70
pubmed: 30472038
Int J Oncol. 2018 Jun;52(6):1787-1800
pubmed: 29568859
J Natl Cancer Inst. 1972 Feb;48(2):347-56
pubmed: 4347034
Stem Cells Int. 2018 Jan 17;2018:9628289
pubmed: 29535786
J Biol Chem. 2000 Sep 8;275(36):27979-88
pubmed: 10856295
Clin Exp Metastasis. 1996 Sep;14(4):358-66
pubmed: 8878410
Int J Oncol. 2012 Nov;41(5):1693-700
pubmed: 22922964
Mol Cell Biol. 2009 Apr;29(8):2011-22
pubmed: 19223473
Front Biosci (Schol Ed). 2010 Jan 01;2(2):558-70
pubmed: 20036968
Lab Chip. 2017 Jan 31;17(3):448-459
pubmed: 28001148
Pharmacol Ther. 2016 Jul;163:94-108
pubmed: 27063403
J Extracell Vesicles. 2017 Aug 8;6(1):1359479
pubmed: 28815003
Am J Pathol. 2002 Feb;160(2):673-80
pubmed: 11839588
Proc Natl Acad Sci U S A. 2012 Aug 21;109(34):13515-20
pubmed: 22869695
FASEB J. 2020 Dec;34(12):16464-16475
pubmed: 33099835
Oncotarget. 2016 Aug 30;7(35):56904-56914
pubmed: 27486877
Am J Pathol. 2012 Oct;181(4):1126-41
pubmed: 22858156
J Neurooncol. 2015 Sep;124(2):237-45
pubmed: 26033547
Front Oncol. 2017 Jun 16;7:120
pubmed: 28670569
Genes Dev. 2015 Jun 15;29(12):1203-17
pubmed: 26109046